Hcq
-
{
- All
- News
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
55 Countries To Get Anti-Malarial Drug From India To Fight Coronavirus
India has approved 55 countris for exporting anti-malarial drug hydroxychloroquine as grants as well as on commercial basis, official sources said on Thursday.
-
Hydroxychloroquine Not To Be Used As COVID-19 Cure: Top Medical Body
The Indian Council of Medical Research (ICMR) on Saturday said that hydroxychloroquine or HCQ should be used as prophylaxis to prevent the coronavirus and not as a treatment for COVID-19.
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
Anti-Malarial Drug, PPEs Prevented COVID-19 Among Health Workers: Report
Sustained intake of anti-malarial drug hyrdoxychloroquine (HCQ) along with appropriate use of personal protective equipment (PPE) led to a significant decline in the odds of healthcare workers getting infected with the coronavirus infection, a study has indicated.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
55 Countries To Get Anti-Malarial Drug From India To Fight Coronavirus
India has approved 55 countris for exporting anti-malarial drug hydroxychloroquine as grants as well as on commercial basis, official sources said on Thursday.
-
Hydroxychloroquine Not To Be Used As COVID-19 Cure: Top Medical Body
The Indian Council of Medical Research (ICMR) on Saturday said that hydroxychloroquine or HCQ should be used as prophylaxis to prevent the coronavirus and not as a treatment for COVID-19.
